Mark G. Lebwohl

PROFESSOR & CHAIR Dermatology

Print Profile

Email

mark.lebwohl@mountsinai.org

Specialty

Certifications

American Board of Dermatology
American Board of Internal Medicine

Clinical Focus

Skin Cancer

Education

MD, Harvard Medical School
Residency, Internal Medicine
Mount Sinai Hospital
Residency, Dermatology
Mount Sinai Hospital

Biography

Dr. Mark Lebwohl graduated summa cum laude from Columbia College in 1974 and graduated from Harvard Medical School in 1978. He completed residencies in internal medicine and dermatology, both at Mount Sinai.

Dr. Lebwohl has been practicing dermatology since 1983. He is professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine. Dr. Lebwohl has served as president of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, and as chairman of the Dermatology Section of the New York Academy of Medicine. Dr. Lebwohl has served as chairman of the Psoriasis Task Force of the American Academy of Dermatology, and has directed the AAD's annual Psoriasis Symposium, Diagnostic Update Symposium and Therapeutics Symposium.

Dr. Lebwohl is chairman of the Medical Board of the National Psoriasis Foundation. He is the founding editor of Psoriasis Forum as well as medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance. He is on the editorial board of the Journal of the American Academy of Dermatology and is editor of the Dermatology Section of Scientific American Medicine, now called ACP Medicine. Dr. Lebwohl has chaired numerous symposia and has written or edited several books including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading book on dermatologic therapy, Treatment of Skin Disease. His books have been translated into numerous foreign languages, including French, Portuguese, and Polish. Other books include Difficult Diagnoses in Dermatology and Psoriasis. He has authored or co-authored over 500 publications including articles, chapters and abstracts. Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments.

Dr. Lebwohl discusses skin cancer in The Daily News feature The Daily Check Up. View the PDF.

Awards

-
Best Doctors
New York Magazine
-
President's Volunteer Service Award
-
Best Teacher & Mentor of the Millenium
Dermatology Residents, Mount Sinai
-
American Academy of Dermatology Bronze Award
Leadership Circle for Volunteerism
-
Presidential Citation
American Academy of Dermatology
2006 - 2011
America's Top Doctors
Castle Connolly

Publications

Koo JM, Lebwohl MG, Lee CS, editors. Mild-to-Moderate Psoriasis (2006). New York, Informa Healthcare;.

Lebwohl M, Heymann WR, Berth-Jones J, Coulson I, editors. Treatment of Skin Disease, 3rd edition (2010). London, Mosby;.

Lebwohl MG. The Skin and Systemic Disease: A Color Atlas and Text, 2nd edition (2004). New York, Churchill Livingstone;.

Lebwohl M, Zanolli M, editors. Psoriasis (1995). Philadelphia, Dermatologic Clinics of North America. W. B. Saunders;.

Lebwohl M. Atlas of the Skin and Systemic Disease (1995). New York, Churchill Livingstone;.

Lebwohl M, editor. Difficult Diagnoses in Dermatology (1988). New York, Churchill Livingston;.

Industry Relationships

Physicians and scientists on the faculty of Mount Sinai School of Medicine often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Lebwohl during 2011 and/or 2012. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

AbGenomics International Inc.; Allos Therapeutics, Inc.; Almirall, S.A.; Amgen Inc.; Anacor Pharmaceuticals, Inc.; Astellas Pharma Inc.; BioLineRx, Ltd.; Celgene Corporation; Covagen AG; DermaGenoma, Inc.; Dermipsor Ltd.; Genentech, Inc.; Glenmark Generics Inc. (GGI), USA, formerly Glenmark Pharmaceuticals Inc.; Helix BioMedix; LEO Pharma Inc.; Luitpold Pharmaceuticals, Inc.; Maruho Co.,Ltd.; Novartis; Onset Dermatologics, formerly Onset Therapeutics; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Ranbaxy Laboratories Limited; Stiefel Laboratories, Inc., a GSK company; Valeant Pharmaceuticals International, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://www.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central